/PRNewswire/ Coriolis Pharma, a globally operating service provider for R&D and GMP drug product development, R&D and GMP analytics and sterile drug product.
Coriolis Pharma secures investment from KKR to support next steps in growth and to expand global footprintNewly formed KKR platform Frontier Biosolutions and its globally renowned experts will serve as advisors to Coriolis PharmaMARTINSRIED-MUNICH, Germany, October 16, 2023 / B3C newswire / Coriolis Pharma, a glo.
Prof. Dr. Reza Nejadnik's research at the University of Iowa, College of Pharmacy, is focused on protein pharmaceuticals, their formulation and characterization, and interaction of biologics with interfaces.MARTINSRIED-MUNICH, Germany, February 01, 2023 / B3C newswire / Coriolis Pharma, a globally operating servi.
Coriolis Pharma, a globally operating service provider and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, including cell and gene therapy products and vaccines, is strengthening its scientific advisory board with the appointment of Bruce Kerwin .
Coriolis Pharma, a globally operating contract research and development organization (CRDO) and one of the world leaders in formulation research and development of (bio)pharmaceutical drugs, ATMP´s and vaccines, is expanding its current headquarters to form a new Campus as the next step in its growth strategy .